De Laurenzi V, Melino G
IDI-IRCCS Biochemistry Lab, Department of Experimental Medicine, University Tor Vergata, Rome, Italy.
Mol Cell Biol. 2001 Jan;21(1):148-55. doi: 10.1128/MCB.21.1.148-155.2001.
Transglutaminase 2 (TGase 2), or tissue transglutaminase, catalyzes either epsilon-(gamma-glutamyl)lysine or N(1), N(8)-(gamma-glutamyl)spermidine isopeptide bonds. TGase 2 expression has been associated with apoptosis, and it has been proposed that its activation should lead to the irreversible assembly of a cross-linked protein scaffold in dead cells. Thus, TGase 2-catalyzed protein polymerization contributes to the ultrastructural changes typical of dying apoptotic cells; it stabilizes the integrity of the apoptotic cells, preventing the release of harmful intracellular components into the extracellular space and, consequently, inflammation and scar formation. In order to perform a targeted disruption of the enzyme, we prepared a construct deleting part of exons 5 and 6, containing the active site, and intron 5. Complete absence of TGase 2 was demonstrated by reverse transcription-PCR and Western blot analysis. TGase activity measured on liver and thymus extracts showed, however, a minimal residual activity in TGase 2(-/-) mice. PCR analysis of mRNA extracted from the same tissues demonstrated that at least TGase 1 (normally present in the skin) is also expressed in these tissues and contributes to this residual activity. TGase 2(-/-) mice showed no major developmental abnormalities, and histological examination of the major organs appeared normal. Induction of apoptosis ex vivo in TGase 2(-/-) thymocytes (by CD95, dexamethasone, etoposide, and H(2)O(2)) and in vitro on TGase 2(-/-) mouse embryonal fibroblasts (by retinoids, UV, and H(2)O(2)) showed no significant differences. A reduction in cross-linked apoptotic bodies with a modestly increased release of lactate dehydrogenase has been detected in some cases. Together our results show that TGase 2 is not a crucial component of the main pathway of the apoptotic program. It is possible that the residual enzymatic activity, due to TGase 1 or redundancy of other still-unidentified TGases, can compensate for the lack of TGase 2.
转谷氨酰胺酶2(TGase 2),即组织转谷氨酰胺酶,催化ε-(γ-谷氨酰基)赖氨酸或N(1),N(8)-(γ-谷氨酰基)亚精胺异肽键的形成。TGase 2的表达与细胞凋亡有关,有人提出其激活会导致死亡细胞中交联蛋白支架的不可逆组装。因此,TGase 2催化的蛋白质聚合作用导致了典型凋亡细胞的超微结构变化;它稳定了凋亡细胞的完整性,防止有害的细胞内成分释放到细胞外空间,从而避免炎症和瘢痕形成。为了对该酶进行靶向破坏,我们制备了一个构建体,缺失了包含活性位点的外显子5和6的部分以及内含子5。通过逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹分析证实了TGase 2完全缺失。然而,对肝脏和胸腺提取物进行的TGase活性测定显示,TGase 2基因敲除(TGase 2(-/-))小鼠中存在最小的残余活性。对从相同组织中提取的mRNA进行的PCR分析表明,至少转谷氨酰胺酶1(通常存在于皮肤中)也在这些组织中表达,并导致了这种残余活性。TGase 2(-/-)小鼠未表现出主要的发育异常,主要器官的组织学检查显示正常。在体外诱导TGase 2(-/-)胸腺细胞凋亡(通过CD95、地塞米松、依托泊苷和H₂O₂)以及在体外诱导TGase 2(-/-)小鼠胚胎成纤维细胞凋亡(通过类视黄醇、紫外线和H₂O₂)均未显示出显著差异。在某些情况下,检测到交联凋亡小体减少,同时乳酸脱氢酶释放略有增加。我们的结果共同表明,TGase 2不是凋亡程序主要途径的关键组成部分。由于TGase 1或其他尚未鉴定的转谷氨酰胺酶的冗余导致的残余酶活性,有可能补偿TGase 2的缺失。